Literature DB >> 18063415

Perianal fistulizing Crohn's disease: a call to action.

Michael A Kamm1, Siew C Ng.   

Abstract

The advent of biological therapies has focused attention on the importance of healing luminal Crohn's disease, thereby modifying the disease course. Perianal fistulas are common in Crohn's disease and often have a poor prognosis, with permanent sphincter and perineal tissue destruction. The importance of healing these fistulas has been less well appreciated. Management still often is left in surgical hands alone, rather than the optimal combination of surgery, infection control, and immunosuppression. Drug therapy often is haphazard, and the means of assessing healing over a long time period has been characterized poorly. Recent studies have suggested that many of these patients can achieve fistula healing, at least in the medium term. We therefore call for more active intervention, with the goal of healing, in these sick patients. Perianal fistulas lead to substantial physical and emotional distress because of pain, discharge, incontinence, perineal and genital disfigurement, and slow resolution even with treatment. The advent of accurate anal imaging, improved knowledge of surgical outcomes, and potent biological therapies make it timely to reflect on current best-management strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063415     DOI: 10.1016/j.cgh.2007.10.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  5 in total

1.  A simplified method for anal ultrasonography: assessment of patient satisfaction and the simplicity of the procedure.

Authors:  D Castellani; E Antonelli; G Sabatino; V Giuliano; A Morelli; G Bassotti
Journal:  Tech Coloproctol       Date:  2008-08-05       Impact factor: 3.781

2.  Endoanal ultrasonography may distinguish Crohn's anal fistulae from cryptoglandular fistulae in patients with Crohn's disease: a cross-sectional study.

Authors:  J Blom; P O Nyström; U Gunnarsson; K Strigård
Journal:  Tech Coloproctol       Date:  2011-07-15       Impact factor: 3.781

3.  Fistulizing Crohn's Disease.

Authors:  Michael Scharl; Gerhard Rogler; Luc Biedermann
Journal:  Clin Transl Gastroenterol       Date:  2017-07-13       Impact factor: 4.488

4.  Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease.

Authors:  Ilse Molendijk; Marjolijn Duijvestein; Andrea E van der Meulen-de Jong; Welmoed K van Deen; Marloes Swets; Daniel W Hommes; Hein W Verspaget
Journal:  J Allergy (Cairo)       Date:  2012-09-20

5.  Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.

Authors:  Jaeyoung Chun; Jong Pil Im; Ji Won Kim; Kook Lae Lee; Chang Hwan Choi; Hyunsoo Kim; Jae Hee Cheon; Byong Duk Ye; Young-Ho Kim; You Sun Kim; Yoon Tae Jeen; Dong Soo Han; Won Ho Kim; Joo Sung Kim
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.